BetterScholar BetterScholar
5
Role
Title
Level Year L/R
🐜 Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
263 auth. Jonathan D Spicer, M. Garassino, Heather A. Wakelee, Moishe Liberman, T. Kato, Masahiro Tsuboi, Se-Hoon Lee, Kevin Chen, C. Dooms, M. Majem, E. Eigendorff, G. Martinengo, O. Bylicki, D. Rodríguez-Abreu, J. Chaft, ... S. Novello, Jing Yang, A. Arunachalam, S.M. Keller, A. Samkari, Shugeng Gao, S. Afanasyev, Samreen Ahmed, Todd Alekshun, Gustavo Alves, Ian Anderson, L.H. Araujo, A. Arkhipov, Arvind Arora, Jie Bai, Paul Begin, Aleksandr Belonogov, H. Bérard, Radu Berceanu-Ion, R. B. Caro, Igor Bondarenko, Reiner Bonnet, Joaquim Bosch Barrera, Carlos Brocca, Maciej Bryl, Alessandra Bulotta, A. C. Blanco, E. Carcereny, Leticia Carvalho, C. Cebotaru, J. Chaft, V. Charu, Fabio Chaves, Jun Chen, Haiquan Chen, Qixun Chen, Kevin Chen, C. Chiang, Chao-Hua Chiu, S. Cicėnas, Elena Ciubotaru, T. Ciuleanu, Ioana Ciurescu, Patrick Cobb, Corlia Coetzee, Dearbhaile Collins, D. Cortinovis, Kimberly Costas, Dan Costin, E. Cronemberger, Raymund Cuevo, S. Cuffe, P. Marchi, Tadeu de Paiva Junior, A. Delmonte, I. Demedts, K. Deschepper, Josiane Dias, B. Duchemann, Carolina Dutra, H. Duvivier, Vinicius Ernani, M. Faehling, Luiza Faria, Alexander Fedenko, Hiran Fernando, Roberto Ferrara, Vittorio Ferrari, Gene Finley, P. Fix, M.B. Flores, S. Fourie, Fabio A. Franke, Klaus-Peter Frohling, Muhammad Furqan, Cristian Gal, Robert Galamaga, D. Ganea, A. Ganti, M. Garassino, R. Gentzler, Luca Gianni, M. Gilli, N. Girard, Bojidar Goranov, V. Gregorc, A. Greystoke, Salvatore Grisanti, Christian Grohé, Michael Guarino, Jose Luiz Guimaraes, F. Guisier, Bal'azs P. Halmos, Z. Hammoud, Ji-Youn Han, A. Hegmane, Fook Yew Heng, H. Horinouchi, Y. Horio, Jian Hu, Hsu-Ching Huang, R. Hui, Norihiko Ikeda, S. Intagliata, Ingrid Iordan, C. Jacobs, Kirti Jain, Sushil Jain, Tao Jiang, N. Karaseva, P. Kaywin, Shayma Kazmi, R. Keresztes, Sarah Khan, Jhingook Kim, Olena Kolesnik, O. Kolesnik, J. Kollmeier, Takefumi Komiya, Michael Koontz, Yuliia Krasnohrud, Timothy Kristedja, A. Kryzhanivska, H. Kuroda, K. Laktionov, M. Lambrechts, S. Lang, A. Langleben, M. Lehmann, E. Levchenko, Oleh Levenko, Shanqing Li, Bin-Chi Liao, I. Lima, Geoffrey Liu, Theresa Liu-Dumlao, G. Russo, Yan Yan Lou, A. Lowczak, Alexander Luft, Shaohua Ma, M. M. Tarruella, Krytsyna Makles, G. Martinengo, A. Marti, Danielli Matias, J. Mazières, L. Mazilu, B. Mennecier, M. Migliorino, J. Misleh, Julian Molina, I. Morbeck, Annette Mueller, S. Muto, Ernest Nadal Alforja, Alfiya Nesterova, Wataru Nishio, Jiaxin Niu, M.E.R. O'Brien, Steven O'Day, F. Ogliari, Morihito Okada, Yong Kek Pang, Viktor Paramonov, A. Pastor, Ireneusz Pawlak, F. Piantedosi, Theodore Pollock, Tony Pope, J.M. Puig, S. Radhi, Suman Rao, C. Rathnasabapathy, M. Reck, A. Reinacher-Schick, Patricia Rich, Mathias Ritgen, A. Rittmeyer, Elisa Roca, D. Rodríguez-Abreu, Paul Ruff, Igor Rybkin, H. Saji, Yukinori Sakao, A. Sangal, A. Santoro, Rodrigo Sardenberg, P. Savvides, R. Scheusan, Joan H. Schiller, Lana Schumacher, M. Serke, Byoung Yong Shim, J. Shimizu, Y. Shio, A. Sibille, Robert Siegel, D. Signorelli, Maria Smagina, Iryna Sokur, Jonathan D Spicer, Gordan Srkalovic, L. Stampleman, A. Starodub, K. Stencel, Kenji Sugio, V. Surmont, Hiroyuki Suzuki, J. Tabacof, K. Takamochi, Lijie Tan, Fumihiro Tanaka, M. Tatangelo, D. Täuscher, Carlos Teixeira, Luc Thiberville, D. Trukhin, Chen-Liang Tsai, A. Ungureanu, G. Ursol, T. Vanakesa, Johan F. Vansteenkiste, M. Varela, M. Villalona-Calero, L. Villaruz, Gunther Vogel, Nataliia Voitko, Qun Wang, Wenxiang Wang, Chin-Chou Wang, Sarah Wang, T. Wehler, Benny Weksler, M. Wermke, C. Wesseler, Hubert Wirtz, Mark Wong, Xiaolong Yan, Yue Yang, Kong Leong Yu, X. Zasadny, Marius Žemaitis, Lanjun Zhang, Guofang Zhao, Qing Zhao, Yuming Zhu, B. Żurawski
3 2024
3
🐜
🐜 PL03.13 Osimertinib With/Without Platinum-Based Chemotherapy as First-line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA2)
21 auth. P. Janne, D. Planchard, Y. Cheng, J.C. Yang, N. Yanagitani, S. Kim, S. Sugawara, Y. Yu, Y. Fan, S. Geater, ... K. Laktionov, C. Lee, N. Valdivieso, S. Ahmed, J. Maurel, I. Andrasina, J. Goldman, D. Ghiorghiu, D. Kulkarni, X. Huang, K. Kobayashi
3 2023
3
🐜
🐜 Durvalumab With or Without Tremelimumab in Combination With Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes from the Phase 3 POSEIDON Trial.
22 auth. S. Peters, B.C. Cho, Alexander Luft, J. Alatorre-Alexander, S. Geater, K. Laktionov, D. Trukhin, Sang-We Kim, G. Ursol, M. Hussein, ... F.L. Lim, Cheng-Ta Yang, L.H. Araujo, H. Saito, Niels Reinmuth, C. Lowery, H. Mann, R. Stewart, Haiyi Jiang, E. Garon, T. Mok, Melissa L Johnson
2 2024
2
🐜
🐜 LBA81 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial
20 auth. S. Senan, D. Spigel, B. C. Cho, K. Laktionov, Y. Zenke, K. Lee, Q. Wang, A. Navarro Mendivil, E. Buchmeier, S. Sezgin Goksu, ... A. Badzio, A. Shi, D.B. Daniel, M. Zemanova, P. Iyengar, L. Paz-Ares, L. Szadkowski, P. Chugh, W.C.V. Lai, Y. Cheng
2 2024
2
🐜
🐜 LBA68 FLAURA2: Safety and CNS outcomes of first-line (1L) osimertinib (osi) ± chemotherapy (CTx) in EGFRm advanced NSCLC
20 auth. D. Planchard, P. Jänne, Y. Cheng, C. Lee, K. Laktionov, T-Y. Yang, Y. Yu, T. Kato, L. Jiang, B. Chewaskulyong, ... S. Lucien Geater, J. Maurel, C. Rojas, L. Havel, F. Shepherd, K. Tanaka, D. Ghiorghiu, E. Armenteros Monterroso, X. Huang, J.C. Yang
1 2023
1
🐜